2,377
Views
66
CrossRef citations to date
0
Altmetric
Original Research

Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy

, , , , &
Article: e27884 | Received 03 Dec 2013, Accepted 16 Jan 2014, Published online: 27 Feb 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (19)

Elise F. Nassif, Constance Thibault, Stéphane Oudard & Jérôme Galon. (2021) Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer. OncoImmunology 10:1.
Read now
Gautier Stoll, Yuting Ma, Heng Yang, Oliver Kepp, Laurence Zitvogel & Guido Kroemer. (2017) Pro-necrotic molecules impact local immunosurveillance in human breast cancer. OncoImmunology 6:4.
Read now
Delia J. Nelson, Briony Clark, Kylie Munyard, Vincent Williams, David Groth, Jespal Gill, Henry Preston & Arlene Chan. (2017) A review of the importance of immune responses in luminal B breast cancer. OncoImmunology 6:3.
Read now
Wouter Hendrickx, Ines Simeone, Samreen Anjum, Younes Mokrab, François Bertucci, Pascal Finetti, Giuseppe Curigliano, Barbara Seliger, Luigi Cerulo, Sara Tomei, Lucia Gemma Delogu, Cristina Maccalli, Ena Wang, Lance D. Miller, Francesco M. Marincola, Michele Ceccarelli & Davide Bedognetti. (2017) Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis. OncoImmunology 6:2.
Read now
Nina Eissler, Yumeng Mao, David Brodin, Philippa Reuterswärd, Helene Andersson Svahn, John Inge Johnsen, Rolf Kiessling & Per Kogner. (2016) Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade. OncoImmunology 5:12.
Read now
Michaela Semeraro, Julien Adam, Gautier Stoll, Emilie Louvet, Kariman Chaba, Vichnou Poirier-Colame, Allan Sauvat, Laura Senovilla, Erika Vacchelli, Norma Bloy, Juliette Humeau, Aitziber Buque, Oliver Kepp, Laurence Zitvogel, Fabrice André, Marie-Christine Mathieu, Suzette Delaloge & Guido Kroemer. (2016) The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ. OncoImmunology 5:10.
Read now
Gautier Stoll, Kristina Iribarren, Judith Michels, Alexandra Leary, Laurence Zitvogel, Isabelle Cremer & Guido Kroemer. (2016) Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer. OncoImmunology 5:7.
Read now
Sylvain Ladoire, Laura Senovilla, David Enot, François Ghiringhelli, Vichnou Poirier-Colame, Kariman Chaba, Gulsun Erdag, Jochen T. Schaefer, Donna H. Deacon, Laurence Zitvogel, Craig L. Slingluff$suffix/text()$suffix/text() & Guido Kroemer. (2016) Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate. OncoImmunology 5:6.
Read now
Elisa E. Baracco, Federico Pietrocola, Aitziber Buqué, Norma Bloy, Laura Senovilla, Laurence Zitvogel, Erika Vacchelli & Guido Kroemer. (2016) Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer. OncoImmunology 5:6.
Read now
Erika Vacchelli, Yuting Ma, Elisa E. Baracco, Laurence Zitvogel & Guido Kroemer. (2016) Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1. OncoImmunology 5:5.
Read now
Sylvain Ladoire, David Enot, Laura Senovilla, François Ghiringhelli, Vichnou Poirier-Colame, Kariman Chaba, Michaela Semeraro, Marie Chaix, Frédérique Penault-Llorca, Laurent Arnould, Marie Laure Poillot, Patrick Arveux, Suzette Delaloge, Fabrice Andre, Laurence Zitvogel & Guido Kroemer. (2016) The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer. Autophagy 12:5, pages 864-875.
Read now
Sylvain Ladoire, David Enot, Fabrice Andre, Laurence Zitvogel & Guido Kroemer. (2016) Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy. OncoImmunology 5:2.
Read now
Heng Yang, Takahiro Yamazaki, Federico Pietrocola, Heng Zhou, Laurence Zitvogel, Yuting Ma & Guido Kroemer. (2016) Improvement of immunogenic chemotherapy by STAT3 inhibition. OncoImmunology 5:2.
Read now
Erika Vacchelli, Antonella Sistigu, Takahiro Yamazaki, Ilio Vitale, Laurence Zitvogel & Guido Kroemer. (2015) Autocrine signaling of type 1 interferons in successful anticancer chemotherapy . OncoImmunology 4:8.
Read now
Oliver Kepp, Laura Senovilla, Ilio Vitale, Erika Vacchelli, Sandy Adjemian, Patrizia Agostinis, Lionel Apetoh, Fernando Aranda, Vincenzo Barnaba, Norma Bloy, Laura Bracci, Karine Breckpot, David Brough, Aitziber Buqué, Maria G. Castro, Mara Cirone, Maria I. Colombo, Isabelle Cremer, Sandra Demaria, Luciana Dini, Aristides G. Eliopoulos, Alberto Faggioni, Silvia C. Formenti, Jitka Fučíková, Lucia Gabriele, Udo S. Gaipl, Jérôme Galon, Abhishek Garg, François Ghiringhelli, Nathalia A. Giese, Zong Sheng Guo, Akseli Hemminki, Martin Herrmann, James W. Hodge, Stefan Holdenrieder, Jamie Honeychurch, Hong-Min Hu, Xing Huang, Tim M. Illidge, Koji Kono, Mladen Korbelik, Dmitri V. Krysko, Sherene Loi, Pedro R. Lowenstein, Enrico Lugli, Yuting Ma, Frank Madeo, Angelo A. Manfredi, Isabelle Martins, Domenico Mavilio, Laurie Menger, Nicolò Merendino, Michael Michaud, Gregoire Mignot, Karen L. Mossman, Gabriele Multhoff, Rudolf Oehler, Fabio Palombo, Theocharis Panaretakis, Jonathan Pol, Enrico Proietti, Jean-Ehrland Ricci, Chiara Riganti, Patrizia Rovere-Querini, Anna Rubartelli, Antonella Sistigu, Mark J. Smyth, Juergen Sonnemann, Radek Spisek, John Stagg, Abdul Qader Sukkurwala, Eric Tartour, Andrew Thorburn, Stephen H. Thorne, Peter Vandenabeele, Francesca Velotti, Samuel T. Workenhe, Haining Yang, Wei-Xing Zong, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Consensus guidelines for the detection of immunogenic cell death. OncoImmunology 3:9.
Read now
Davide Bedognetti, Ena Wang & Francesco M Marincola. (2014) Meta-analysis and metagenes. OncoImmunology 3:4.
Read now

Articles from other publishers (47)

Yue Xi, Yingchun Zhang, Kun Zheng, Jiawei Zou, Lv Gui, Xin Zou, Liang Chen, Jie Hao & Yiming Zhang. (2023) A chemotherapy response prediction model derived from tumor-promoting B and Tregs and proinflammatory macrophages in HGSOC. Frontiers in Oncology 13.
Crossref
Yusong Wang, Xiaoyan Liu, Keda Yu, Shouping Xu, Pengfei Qiu, Xinwen Zhang, Mozhi Wang & Yingying Xu. (2023) A generalized non-linear model predicting efficacy of neoadjuvant therapy in HER2+ breast cancer. iScience 26:4, pages 106330.
Crossref
Jie Luo, Lanqi Gong, Yuma Yang, Yu Zhang, Qin Liu, Lu Bai, Xiaona Fang, Baifeng Zhang, Jiao Huang, Ming Liu, Beilei Liu, Ying Tang, Ching Ngar Wong, Jinlin Huang, Shan Liu, Shanshan Li, Tao Ding, Kwan Man, Victor Ho-Fun Lee, Yan Li, Stephanie Ma & Xin-Yuan Guan. (2023) Enhanced mitophagy driven by ADAR1-GLI1 editing supports the self-renewal of cancer stem cells in HCC. Hepatology.
Crossref
Caitlin M. Tilsed, Nicola Principe, Joel Kidman, Wee Loong Chin, M. Lizeth Orozco Morales, Rachael M. Zemek, Jonathan Chee, Rasa Islam, Vanessa S. Fear, Catherine Forbes, Wayne J. Aston, Maud Jansen, Abha Chopra, Timo Lassmann, Anna K. Nowak, Scott A. Fisher, Richard A. Lake & W. Joost Lesterhuis. (2022) CD4+ T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment responsive to chemotherapy. Cell Reports 41:13, pages 111874.
Crossref
Rita Ribeiro, Maria João Carvalho, João Goncalves & João Nuno Moreira. (2022) Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities. Frontiers in Molecular Biosciences 9.
Crossref
Cheng Zhang, Cristina Correia, Taylor M. Weiskittel, Shyang Hong Tan, Kevin Meng-Lin, Grace T. Yu, Jingwen Yao, Kok Siong Yeo, Shizhen Zhu, Choong Yong Ung & Hu Li. (2022) A Knowledge-Based Discovery Approach Couples Artificial Neural Networks With Weight Engineering to Uncover Immune-Related Processes Underpinning Clinical Traits of Breast Cancer. Frontiers in Immunology 13.
Crossref
Giorgia Centonze, Dora Natalini, Alessio Piccolantonio, Vincenzo Salemme, Alessandro Morellato, Pietro Arina, Chiara Riganti & Paola Defilippi. (2022) Cholesterol and Its Derivatives: Multifaceted Players in Breast Cancer Progression. Frontiers in Oncology 12.
Crossref
Sana Arnouk, Timo W.M. De Groof & Jo A. Van Ginderachter. (2022) Imaging and therapeutic targeting of the tumor immune microenvironment with biologics. Advanced Drug Delivery Reviews 184, pages 114239.
Crossref
Simone Ragaini, Sarah Wagner, Giovanni Marconi, Sarah ParisiChiara Sartor, Jacopo NanniGianluca CristianoAnnalisa TalamiMatteo OliviDarina OcadlikovaMarilena Ciciarello, Giulia CorradiEmanuela Ottaviani, Cristina Papayannidis, Stefania Paolini, Jayakumar VadakekolathuMichele Cavo, Sergio Rutella & Antonio Curti. (2022) An IDO1 -related immune gene signature predicts overall survival in acute myeloid leukemia . Blood Advances 6:1, pages 87-99.
Crossref
Amos Kirilovsky, Carine El Sissy, Guy Zeitoun, Florence Marliot, Nacilla Haicheur, Christine Lagorce-Pagès, Julien Taieb, Mehdi Karoui, Petra Custers, Edina Dizdarevic, Soledad Iseas, Torben Frøstrup Hansen, Lars Henrik Jensen, Geerard Beets, Jean Pierre Gérard, Mireia Castillo-Martin, Nuno Figueiredo, Angelita Habr-Gama, Rodrigo Perez, Jérôme Galon & Franck Pagès. (2022) The “Immunoscore” in rectal cancer: could we search quality beyond quantity of life?. Oncotarget 13:1, pages 18-31.
Crossref
Margaux Saillard, Mara Cenerenti, Pedro Romero & Camilla Jandus. (2021) Impact of Immunotherapy on CD4 T Cell Phenotypes and Function in Cancer. Vaccines 9:5, pages 454.
Crossref
Chen Suo, Huiyao Chen, Franciszek Binczyk, Renjia Zhao, Jiahui Fan, Xiaorong Yang, Ziyu Yuan, David Kreil, Paweł Łabaj, Tiejun Zhang, Ming Lu, Li Jin, Joanna Polańska, Xingdong Chen & Weimin Ye. (2021) Tumor infiltrating lymphocyte signature is associated with single nucleotide polymorphisms and predicts survival in esophageal squamous cell carcinoma patients. Aging 13:7, pages 10369-10386.
Crossref
Kunpeng Wang, Xinyi Chen, Chong Jin, Jinggang Mo, Hao Jiang, Bin Yi & Xiang Chen. (2020) A novel immune-related genes prognosis biomarker for hepatocellular carcinoma. Aging 13:1, pages 675-693.
Crossref
Daniela Bruni, Helen K. Angell & Jérôme Galon. (2020) The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nature Reviews Cancer 20:11, pages 662-680.
Crossref
Neetha Rajan Latha, Arathi Rajan, Revathy Nadhan, Sarada Achyutuni, Satheesh Kumar Sengodan, Sreelatha Krishnakumar Hemalatha, Geetu Rose Varghese, Ratheeshkumar Thankappan, Neethu Krishnan, Dipyaman Patra, Arathy Warrier & Priya Srinivas. (2020) Gene expression signatures: A tool for analysis of breast cancer prognosis and therapy. Critical Reviews in Oncology/Hematology 151, pages 102964.
Crossref
Vanessa Acebes-Fernández, Alicia Landeira-Viñuela, Pablo Juanes-Velasco, Angela-Patricia Hernández, Andrea Otazo-Perez, Raúl Manzano-Román, Rafael Gongora & Manuel Fuentes. (2020) Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers. Nanomaterials 10:7, pages 1274.
Crossref
Lude Zhu, Guolong Zhang, Peiru Wang, Linglin Zhang, Jie Ji, Xiaojing Liu, Zhongxia Zhou, Jingjun Zhao & Xiuli Wang. (2019) The effect of C-X-C motif chemokine ligand 13 in cutaneous squamous cell carcinoma treated with aminolevulinic acid-photodynamic therapy. Photodiagnosis and Photodynamic Therapy 26, pages 389-394.
Crossref
Claire Buchta Rosean, Tzu-Yu Feng, Francesca N. Azar & Melanie R. Rutkowski. 2019. Immunotherapy of Cancer. Immunotherapy of Cancer 255 294 .
David A. Bernal-Estévez, Oscar García, Ramiro Sánchez & Carlos A. Parra-López. (2018) Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy. BMC Cancer 18:1.
Crossref
François Bertucci, Pascal Finetti, Ines Simeone, Wouter Hendrickx, Ena Wang, Francesco M. Marincola, Patrice Viens, Emilie Mamessier, Michele Ceccarelli, Daniel Birnbaum & Davide Bedognetti. (2018) The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer. British Journal of Cancer 119:11, pages 1383-1391.
Crossref
Francis P. Roche, Ilkka Pietilä, Hiroshi Kaito, Elisabet O. Sjöström, Nadine Sobotzki, Oriol Noguer, Tor Persson Skare, Magnus Essand, Bernd Wollscheid, Michael Welsh & Lena Claesson-Welsh. (2018) Leukocyte Differentiation by Histidine-Rich Glycoprotein/Stanniocalcin-2 Complex Regulates Murine Glioma Growth through Modulation of Antitumor Immunity. Molecular Cancer Therapeutics 17:9, pages 1961-1972.
Crossref
Mariel Garcia-Chagollan, Irma Edith Carranza-Torres, Pilar Carranza-Rosales, Nancy Elena Guzmán-Delgado, Humberto Ramírez-Montoya, María Guadalupe Martínez-Silva, Ignacio Mariscal-Ramirez, Carlos Alfredo Barrón-Gallardo, Ana Laura Pereira-Suárez, Adriana Aguilar-Lemarroy & Luis Felipe Jave-Suárez. (2018) Expression of NK Cell Surface Receptors in Breast Cancer Tissue as Predictors of Resistance to Antineoplastic Treatment. Technology in Cancer Research & Treatment 17, pages 153303381876449.
Crossref
Sacha Gnjatic, Vincenzo Bronte, Laura Rosa Brunet, Marcus O. Butler, Mary L. Disis, Jérôme Galon, Leif G. Hakansson, Brent A. Hanks, Vaios Karanikas, Samir N. Khleif, John M. Kirkwood, Lance D. Miller, Dolores J. Schendel, Isabelle Tanneau, Jon M. Wigginton & Lisa H. Butterfield. (2017) Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy. Journal for ImmunoTherapy of Cancer 5:1.
Crossref
Wolf H. Fridman, Laurence Zitvogel, Catherine Sautès–Fridman & Guido Kroemer. (2017) The immune contexture in cancer prognosis and treatment. Nature Reviews Clinical Oncology 14:12, pages 717-734.
Crossref
Yuting Ma, Jonathan M. Pitt, Qingqing Li & Heng Yang. (2017) The renaissance of anti-neoplastic immunity from tumor cell demise. Immunological Reviews 280:1, pages 194-206.
Crossref
Abhishek D. Garg & Patrizia Agostinis. (2017) Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses. Immunological Reviews 280:1, pages 126-148.
Crossref
Gloria Romagnoli, Meike Wiedermann, Friederike Hübner, Antonia Wenners, Micaela Mathiak, Christoph Röcken, Nicolai Maass, Wolfram Klapper & Ibrahim Alkatout. (2017) Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study. International Journal of Molecular Sciences 18:9, pages 1936.
Crossref
Laxmi Silwal-Pandit, Silje Nord, Hedda von der Lippe Gythfeldt, Elen K. Møller, Thomas Fleischer, Einar Rødland, Marit Krohn, Elin Borgen, Øystein Garred, Tone Olsen, Phuong Vu, Helle Skjerven, Anne Fangberget, Marit M. Holmen, Ellen Schlitchting, Elisabeth Wille, Mette Nordberg Stokke, Hans Kristian Moen Vollan, Vessela Kristensen, Anita Langerød, Steinar Lundgren, Erik Wist, Bjørn Naume, Ole Christian Lingjærde, Anne-Lise Børresen-Dale & Olav Engebraaten. (2017) The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer. Clinical Cancer Research 23:16, pages 4662-4670.
Crossref
Oscar Buisan, Anna Orsola, Joan Areal, Albert Font, Mario Oliveira, Roberto Martinez & Luis Ibarz. (2017) Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer. Clinical Genitourinary Cancer 15:1, pages 145-151.e2.
Crossref
Sarah E. Church & Jérôme Galon. 2017. Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy. Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy 33 49 .
Anne-Sophie Hamy, Hélène Bonsang-Kitzis, Marick Lae, Matahi Moarii, Benjamin Sadacca, Alice Pinheiro, Marion Galliot, Judith Abecassis, Cecile Laurent & Fabien Reyal. (2016) A Stromal Immune Module Correlated with the Response to Neoadjuvant Chemotherapy, Prognosis and Lymphocyte Infiltration in HER2-Positive Breast Carcinoma Is Inversely Correlated with Hormonal Pathways. PLOS ONE 11:12, pages e0167397.
Crossref
Yanhong Wu, Zhenling Deng, Huiru Wang, Wenbo Ma, Chunxia Zhou & Shuren Zhang. (2016) Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model. BMC Immunology 17:1.
Crossref
F. Erlmeier, A.K. Seitz, G. Hatzichristodoulou, L. Stecher, M. Retz, J.E. Gschwend, W. WeichertH.R. Kübler & T. Horn. (2016) The Role of PD-L1 Expression and Intratumoral Lymphocytes in Response to Perioperative Chemotherapy for Urothelial Carcinoma. Bladder Cancer 2:4, pages 425-432.
Crossref
Aliyah M. Weinstein & Walter J. Storkus. (2016) Biosynthesis and Functional Significance of Peripheral Node Addressin in Cancer-Associated TLO. Frontiers in Immunology 7.
Crossref
Lance D. Miller, Jeff A. Chou, Michael A. Black, Cristin Print, Julia Chifman, Angela Alistar, Thomas Putti, Xiaobo Zhou, Davide Bedognetti, Wouter Hendrickx, Ashok Pullikuth, Jonathan Rennhack, Eran R. Andrechek, Sandra Demaria, Ena Wang & Francesco M. Marincola. (2016) Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness. Cancer Immunology Research 4:7, pages 600-610.
Crossref
Davide Bedognetti, Wouter Hendrickx, Michele Ceccarelli, Lance D Miller & Barbara Seliger. (2016) Disentangling the relationship between tumor genetic programs and immune responsiveness. Current Opinion in Immunology 39, pages 150-158.
Crossref
Davide Bedognetti, Cristina Maccalli, Salha B.J. Al Bader, Francesco M. Marincola & Barbara Seliger. (2016) Checkpoint Inhibitors and Their Application in Breast Cancer. Breast Care 11:2, pages 108-115.
Crossref
E Muraro, E Comaro, R Talamini, E Turchet, G Miolo, S Scalone, L Militello, D Lombardi, S Spazzapan, T Perin, S Massarut, D Crivellari, Riccardo Dolcetti & D Martorelli. (2015) Improved Natural Killer cell activity and retained anti-tumor CD8+ T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy. Journal of Translational Medicine 13:1.
Crossref
Abhishek D. Garg, Lorenzo Galluzzi, Lionel Apetoh, Thais Baert, Raymond B. Birge, José Manuel Bravo-San Pedro, Karine Breckpot, David Brough, Ricardo Chaurio, Mara Cirone, An Coosemans, Pierre G. Coulie, Dirk De Ruysscher, Luciana Dini, Peter de Witte, Aleksandra M. Dudek-Peric, Alberto Faggioni, Jitka Fucikova, Udo S. Gaipl, Jakub Golab, Marie-Lise Gougeon, Michael R. Hamblin, Akseli Hemminki, Martin Herrmann, James W. Hodge, Oliver Kepp, Guido Kroemer, Dmitri V. Krysko, Walter G. Land, Frank Madeo, Angelo A. Manfredi, Stephen R. Mattarollo, Christian Maueroder, Nicolò Merendino, Gabriele Multhoff, Thomas Pabst, Jean-Ehrland Ricci, Chiara Riganti, Erminia Romano, Nicole Rufo, Mark J. Smyth, Jürgen Sonnemann, Radek Spisek, John Stagg, Erika Vacchelli, Peter Vandenabeele, Lien Vandenberk, Benoit J. Van den Eynde, Stefaan Van Gool, Francesca Velotti, Laurence Zitvogel & Patrizia Agostinis. (2015) Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in Immunology 6.
Crossref
Davide Bedognetti, Wouter Hendrickx, Francesco M. Marincola & Lance D. Miller. (2015) Prognostic and predictive immune gene signatures in breast cancer. Current Opinion in Oncology 27:6, pages 433-444.
Crossref
Omri Teltsh, Angel Porgador & Eitan Rubin. (2015) Extracting tumor tissue immune status from expression profiles: correlating renal cancer prognosis with tumor-associated immunome. Oncotarget 6:32, pages 33191-33205.
Crossref
Guido Kroemer, Laura Senovilla, Lorenzo Galluzzi, Fabrice André & Laurence Zitvogel. (2015) Natural and therapy-induced immunosurveillance in breast cancer. Nature Medicine 21:10, pages 1128-1138.
Crossref
Gautier Stoll, Laurence Zitvogel & Guido Kroemer. (2015) Immune infiltrate in cancer. Aging 7:6, pages 358-359.
Crossref
Gautier Stoll, Gabriela Bindea, Bernhard Mlecnik, Jérôme Galon, Laurence Zitvogel & Guido Kroemer. (2015) Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies. Oncotarget 6:14, pages 11894-11909.
Crossref
Jae-Hyun Park. 2015. Immunopharmacogenomics. Immunopharmacogenomics 143 155 .
Davide Bedognetti, Sara Tomei, Wouter Hendrickx, Francesco M. Marincola & Ena Wang. 2015. Developments in T Cell Based Cancer Immunotherapies. Developments in T Cell Based Cancer Immunotherapies 99 127 .
Laurence Zitvogel & Guido Kroemer. (2014) CD103+ Dendritic Cells Producing Interleukin-12 in Anticancer Immunosurveillance. Cancer Cell 26:5, pages 591-593.
Crossref